Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverCV
HealthcareNCMUSD

CapsoVision, Inc.

$00123456789.0012345678900123456789+0.6%
52w low (est.) $5.33$8.57 52w high (est.)
Market data
Market cap
USD335.26M
52w range
USD3.43 - USD15.37
Beta
1.00
Sector
Healthcare
Data quality
79/100
Valuation
DCF fair value
USD2.68
Margin of safety
-60.3%
Quality & efficiency
Moat score
31/100
Return on equity
-185.1%
Profit margin
-198.9%
Debt / equity
0.04
Growth & analysts
Revenue growth
+0.3%
Analyst target
USD10.00
Target upside
+48.1%
Analysts
1
Run the 10-point checklist before you buy How these numbers are made

About CapsoVision, Inc.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Valuation

ValueGrowthProfitHealthIncome23QUALITY
Overall Rating
19
Sell
Sell

Derived from filed metrics · High confidence (79% of the inputs available)

Moat Score31
DCF Intrinsic Value
USD2.68-60.3% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD335.26M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+0.3%
Profit Margin
-198.9%
ROE
-185.1%
Debt / Equity
0.04
Beta
1.00
Beaten Down
vs Healthcare sector:Moat 31 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · CV